226 related articles for article (PubMed ID: 19328712)
1. Innovative biomarkers for prostate cancer early diagnosis and progression.
You J; Cozzi P; Walsh B; Willcox M; Kearsley J; Russell P; Li Y
Crit Rev Oncol Hematol; 2010 Jan; 73(1):10-22. PubMed ID: 19328712
[TBL] [Abstract][Full Text] [Related]
2. Urinary biomarkers in prostate cancer detection and monitoring progression.
Wu D; Ni J; Beretov J; Cozzi P; Willcox M; Wasinger V; Walsh B; Graham P; Li Y
Crit Rev Oncol Hematol; 2017 Oct; 118():15-26. PubMed ID: 28917266
[TBL] [Abstract][Full Text] [Related]
3. In the search of novel urine biomarkers for the early diagnosis of prostate cancer. Intracellular or secreted proteins as the target group? Where and how to search for possible biomarkers useful in the everyday clinical practice.
Katafigioti A; Katafigiotis I; Sfoungaristos S; Alamanis C; Stravodimos K; Anastasiou I; Roumelioti E; Duvdevani M; Constantinides C
Arch Ital Urol Androl; 2016 Oct; 88(3):195-200. PubMed ID: 27711093
[TBL] [Abstract][Full Text] [Related]
4. Serum-to-urinary prostate-specific antigen ratio in patients with benign prostatic hyperplasia and prostate cancer.
Hillenbrand M; Bastian M; Steiner M; Zingler C; Müller M; Wolff JM; Seiter H; Schuff-Werner P
Anticancer Res; 2000; 20(6D):4995-6. PubMed ID: 11326656
[TBL] [Abstract][Full Text] [Related]
5. Biomarkers for early prostate cancer detection.
Margreiter M; Stangelberger A; Valimberti E; Herwig R; Djavan B
Minerva Urol Nefrol; 2008 Mar; 60(1):51-60. PubMed ID: 18427435
[TBL] [Abstract][Full Text] [Related]
6. Use of thymosin beta15 as a urinary biomarker in human prostate cancer.
Hutchinson LM; Chang EL; Becker CM; Shih MC; Brice M; DeWolf WC; Gaston SM; Zetter BR
Prostate; 2005 Jul; 64(2):116-27. PubMed ID: 15666387
[TBL] [Abstract][Full Text] [Related]
7. Insulin-like growth factor I (IGF-I) and IGF-binding protein-3 in benign prostatic hyperplasia and prostate cancer.
Khosravi J; Diamandi A; Mistry J; Scorilas A
J Clin Endocrinol Metab; 2001 Feb; 86(2):694-9. PubMed ID: 11158033
[TBL] [Abstract][Full Text] [Related]
8. Prostate-specific antigen: an evolving role in diagnosis, monitoring, and treatment evaluation in prostate cancer.
Payne H; Cornford P
Urol Oncol; 2011; 29(6):593-601. PubMed ID: 20060331
[TBL] [Abstract][Full Text] [Related]
9. [Non- PSA serum markers for the diagnosis of PCa].
Mengual L; Musquera M; Ciudin A; Ribal MJ
Arch Esp Urol; 2015 Apr; 68(3):229-39. PubMed ID: 25948796
[TBL] [Abstract][Full Text] [Related]
10. Molecular markers of prostate cancer.
Bradford TJ; Tomlins SA; Wang X; Chinnaiyan AM
Urol Oncol; 2006; 24(6):538-51. PubMed ID: 17138135
[TBL] [Abstract][Full Text] [Related]
11. Biomarkers for prostate cancer.
Schiffer E
World J Urol; 2007 Dec; 25(6):557-62. PubMed ID: 17690889
[TBL] [Abstract][Full Text] [Related]
12. Beyond prostate-specific antigen: alternate serum markers.
Ramírez ML; Nelson EC; Evans CP
Prostate Cancer Prostatic Dis; 2008; 11(3):216-29. PubMed ID: 18227856
[TBL] [Abstract][Full Text] [Related]
13. Increased discrimination between benign prostatic hyperplasia and prostate cancer through measurement of percentage free PSA.
Wolff JM; Boeckmann W; Effert PJ; Habib FK; Jakse G
Anticancer Res; 1997; 17(4B):2993-4. PubMed ID: 9329583
[TBL] [Abstract][Full Text] [Related]
14. Postoperative PSA and PSA velocity identify presence of prostate cancer after various surgical interventions for benign prostatic hyperplasia.
Helfand BT; Anderson CB; Fought A; Kim DY; Vyas A; McVary KT
Urology; 2009 Jul; 74(1):177-83. PubMed ID: 19428074
[TBL] [Abstract][Full Text] [Related]
15. A panel of five circulating microRNAs as potential biomarkers for prostate cancer.
Chen ZH; Zhang GL; Li HR; Luo JD; Li ZX; Chen GM; Yang J
Prostate; 2012 Sep; 72(13):1443-52. PubMed ID: 22298030
[TBL] [Abstract][Full Text] [Related]
16. Comparison of mRNA, Protein, and Urinary Nucleic Acid Levels of S100A8 and S100A9 between Prostate Cancer and BPH.
Yun SJ; Yan C; Jeong P; Kang HW; Kim YH; Kim EA; Lee OJ; Kim WT; Moon SK; Kim IY; Choi YH; Kim WJ
Ann Surg Oncol; 2015 Jul; 22(7):2439-45. PubMed ID: 25348783
[TBL] [Abstract][Full Text] [Related]
17. Urine biomarkers in prostate cancer.
Ploussard G; de la Taille A
Nat Rev Urol; 2010 Feb; 7(2):101-9. PubMed ID: 20065953
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic and prognostic scoring system for prostate cancer using urine and plasma biomarkers.
Ma W; Diep K; Fritsche HA; Shore N; Albitar M
Genet Test Mol Biomarkers; 2014 Mar; 18(3):156-63. PubMed ID: 24512523
[TBL] [Abstract][Full Text] [Related]
19. [The latest research of the molecular biomarker in prostate cancer].
Ashikari D; Takahashi S
Nihon Rinsho; 2016 Jan; 74(1):50-4. PubMed ID: 26793879
[TBL] [Abstract][Full Text] [Related]
20. The role of proteomics in prostate cancer research: biomarker discovery and validation.
Pin E; Fredolini C; Petricoin EF
Clin Biochem; 2013 Apr; 46(6):524-38. PubMed ID: 23266295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
